Smart Tools, Smarter Choices: Understanding AI and Automation in Clinical Lab RCM
Wednesday, Jan. 28, 2026, 1 p.m. ET
OLP-Regular
Subscribe today for access to
Articles and Reports
Avoid Payer Trouble in Revenue Cycle Management: Best Practices to Stay Ahead of the Most Scrutinized Clinical Lab Services
Part of our Revenue Cycle Management Webinar Series, this event identifies lab services frequently targeted for denials
Emerging Technologies in the Lab: Protect Your Data and Increase Its Value
Key steps labs can take to avoid some of the most common data protection compliance issues related to emerging technologies, and add value
Panel Discussion: What’s Going on with LDTs Regulation?
Regulatory experts will address key questions remaining about LDTs and how labs may wish to address compliance amidst the uncertainty
FDA’s Quality Management System Regulation: What Laboratories Need to Know
This webinar will provide an in-depth overview of the new QMSR requirements and outline key steps laboratories must take to ensure compliance
Lab Workflow Optimization: What to Consider Before You Start
This session will offer an analysis of how instrument consolidations and total laboratory automation can improve lab workflow optimization
Revenue Integrity: Understanding NCCI Policy and Application of the Rules
Learn how to translate NCCI policy statements into layman’s terms with working examples that can be applied within your organization
Washington Update: What Labs Should Know
This Lab Institute presentation offers updates on recent legal and regulatory developments, and how they could affect labs
Lab Enforcement: Current Trends and Compliance Tips for Labs
This Lab Institute presentation shares recent enforcement trends and how labs can avoid compliance risks related to these issues.
Lab Institute Virtual Event: Advancing the Profession of Diagnostic Medicine
Our event equips diagnostic medicine professionals with innovative strategies to advance their practice, enhance patient care, and drive the future of the field
Key Things Labs Need to Know About the FDA’s Final LDTs Rule
This webinar will discuss steps lab leaders will need to take in the near future to ensure they are prepared for the final LDTs rule
A Debate—Resolved: Immunohistochemistry Should Be Regulated As An Assay
Join G2 Intelligence for this interactive discussion about whether clinical immunohistochemistry testing should be a stain or an assay, with our experts offering arguments for and against the proposed changes
